Skip to main content
. 2020 Sep 4;7:581828. doi: 10.3389/fmolb.2020.581828

FIGURE 3.

FIGURE 3

Difference of time to decline of FVC > 10% between pirfenidone and nintedanib subgroups, expressed with Kaplan-Meier curves.